Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of obesity. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://haseebzvbz476527.theobloggers.com/45518556/semaglutide-a-potential-solution-for-metabolic-disorders